Abstract
Objective. To determine the prevalence of fat metaplasia and other structural lesions of the sacroiliac joints associated with axial spondyloarthritis in a nonrheumatological patient population.
Methods. Magnetic resonance imaging examinations that included the pelvis and were performed in patients without known rheumatological disease were used for this retrospective cross-sectional study. These images were evaluated for sacroiliac fat metaplasia, sclerosis, osteophytes, and joint space alterations such as erosions or ankylosis. Patients were divided into 7 age groups (15–24 to ≥ 75 yrs). Prevalence of lesions across age groups was calculated. Possible clinical confounders (e.g., status post radiation, suspected inflammatory bowel disease) were investigated regarding their effect on lesion prevalence and extent, to exclude bias.
Results. A total of 485 patients were enrolled. Fat metaplasia was very common and increased with age, from a prevalence of 50.6% in the age groups < 45, to 94.4% in patients ≥ 75 years. Erosions were uncommon: 0.6% of patients < 45, and 2.6% of the entire study population exhibited this feature, with no detectable age-dependent increase. Sclerosis and osteophytes were detected in 13.7% and 37.0% of patients, respectively. None of the investigated clinical confounders had a significant effect on lesion prevalence.
Conclusion. Our study shows a very high prevalence of fat metaplasia adjacent to the sacroiliac joint in asymptomatic patients, while erosions are extremely uncommon.
Axial spondyloarthritis (axSpA) is a term that describes a group of diseases with a predominant inflammation of the axial skeleton. It may be associated with other clinical conditions, such as enthesitis, peripheral oligoarthritis, or uveitis, and often first manifests in the sacroiliac joints (SIJ)1. While radiography still remains the first-line imaging modality for the diagnosis and classification of axSpA, the value of magnetic resonance imaging (MRI) in the detection of both acute and chronic changes of SIJ during the course of axSpA has been discussed by a task force of the European League Against Rheumatism2 and by the Assessment of SpondyloArthritis international Society3.
One of the chronic lesions described as typical for sacroiliitis is fat metaplasia4,5, which manifests as increased periarticular signal intensity on T1-weighted MR images. Fat metaplasia is assumed to be an intermediate stage between active inflammation and formation of new bone, as in ankylosis4. However, MR signal characteristics of bone in general are dependent on the relative proportions of trabecular bone, fat, and water6. While the proportion of hematopoietic bone marrow decreases gradually with age, the proportion of fat marrow (yellow marrow) increases over time6. Pathological conditions associated with increases in adipose tissue in bone marrow also include aplastic anemia7, osteoporosis and osteopenia8, radiation9, and treatment with certain immunosuppressive agents such as azathioprine10.
Other structural bone changes observed in patients with axSpA include subchondral sclerosis, erosions, bony bridges, and ankylosis11. These changes, however, may also occur in other conditions such as degenerative joint disease12. Further, if these structural changes, as well as alterations in periarticular fat content, are detected by MRI, they are to date not considered definitive of axSpA in the absence of active inflammatory lesions such as bone marrow edema11.
Analysis of structural SIJ damage, still preferentially by conventional radiographs2, is well established for the diagnosis of axSpA and for assessing progression and the response to treatment regimens in the setting of clinical trials. We have recently reported that T1-weighted MRI sequences are superior to conventional radiographs in the detection of erosions of SIJ using low-dose computed tomography (CT) as reference13. Studies have investigated the frequency of structural lesions in patients with postpartum lower back pain14 and asymptomatic hyperparathyroidism15. However, reference data for the occurrence of such structural SIJ lesions on T1-weighted MR images obtained in the normal population are available only for control groups in papers reporting the distribution of findings of axSpA and therefore are either healthy volunteers or patients with nonspecific back pain16,17,18,19.
Our study set out to analyze the prevalence of fat metaplasia, erosions, sclerosis, and alterations of joint width using MRI across age groups in a patient population without known rheumatological disease.
MATERIALS AND METHODS
Our retrospective study included all patients who underwent an MRI examination of the pelvic region at the Department of Radiology of the Charité - Universitätsmedizin Berlin during a 3-year period. Examinations dedicated to the detection of SIJ pathology were not included. A range of possible influencing factors on bone marrow conversion was recorded from the electronic patient records: status post-irradiation of the spine or lower abdomen, immunosuppressive therapy including chemotherapy, hematological disease (especially aplastic anemia), and osteoporosis.
All patients gave written informed consent to anonymized use of their data prior to image acquisition, as part of the routine clinical protocol at our department. The local ethics committee waived approval because of the retrospective nature of our study.
Axial T1-weighted sequences were used for this analysis. Depending on the protocol and body region imaged, these were either conventional spin echo or gradient echo sequences with a slice thickness of 4 mm and 5 mm, respectively. All images were acquired on 1.5 Tesla MRI scanners (SOMATOM Avanto or SOMATOM Symphony, Siemens Healthcare).
A standardized scoring system was defined for the purpose of this evaluation. All items except fat metaplasia (sclerosis, osteophytes, and joint space alterations, including erosions) were evaluated for each joint individually (2 joints per patient). Fat metaplasia was evaluated for the sacrum and ilium separately (4 regions per patient) to identify differences between these bones. A quadrant-based scoring approach as used in most other dedicated scoring systems or axSpA could not be used because only axial images were evaluated.
Expanding on previous definitions11,20, fat metaplasia in our study was not only defined as adjacent to the joint, but also graded semiquantitatively regarding its extent (Figure 1), further developing scoring methods described earlier by our group21. The border of these lesions to the nonarticular side was not clearly defined because of the varying slice thickness of the MRI sequences used. Joint space alterations were scored categorically, and a distinction was made between joint space irregularities (partially irregular joint surface, with preserved continuity of T1 hypointense cortical bone) and definite erosion (definite discontinuity of cortical bone). Both sclerosis and osteophytes were again graded semiquantitatively by measuring their extent and then assigning scoring values. An overview of the resulting score definitions is given in Table 1. Further, an atlas (Figure 1, and Supplementary Figures 1–3, available with the online version of this article) was compiled to aid standardized image interpretation during reading sessions.
All images were systematically evaluated by a radiologist in training (HE, 3 yrs of experience in musculoskeletal radiology), who was blinded to all patient data. Prior to image evaluation, a training session with an expert radiologist (KGH, 15 years of experience in musculoskeletal radiology) was carried out on 20 test datasets, which were not part of the main analysis. To calculate interrater reliability as a measure of internal consistency of the scoring system applied, the expert radiologist (KGH) also scored a random sample of 10% of the study population.
Statistical analyses were carried out using IBM SPSS Version 22 (IBM Corp.). Descriptive analysis included calculation of percentages of patient characteristics. Patterns of fat metaplasia (sacrum and ilium individually) were compiled for men and women, and each age group, separately.
A sum score of all individual scorings of fatty lesions per patient was calculated (4 regions per patient, sum score range 0–20). Pearson correlation coefficients (Pearson r) were calculated to detect correlations between age and extent of fat metaplasia. Patients with a sum score of 3 or higher were considered overall positive for fat metaplasia, to avoid bias resulting from subtle lesions. Patients with definite erosion (score 2 in the category joint space) on 1 or both sides were considered positive for erosion. Patients with a score of ≥ 1 for sclerosis or osteophytes on either side in the corresponding category were considered positive for the respective characteristic. To test for significance of any age-related trends, the Jonckheere-Terpstra test was applied.
Subgroups chosen for further analysis were the predefined clinical confounders retrieved from patient records (irradiation, immunosuppression, hematological disease, and osteoporosis) as well as suspected inflammatory bowel disease (IBD; in this setting, this was defined as all patients who received a dedicated small intestine examination such as MRI Sellink). T tests for unpaired samples were used to detect differences in mean sum scores between subgroups. Kendall tau c was used to detect associations between degrees of fat metaplasia and clinical data (radiotherapy, immunosuppression, osteoporosis). Intraclass correlation coefficients (ICC) were calculated to test for interrater reliability of the scoring system using a 2-way mixed model [ICC (3,2)]22. A significance level of p < 0.05 was assumed for all tests.
RESULTS
Patient population
A total of 485 patients were identified for enrollment in this retrospective analysis. Patients with missing or incomplete clinical data were excluded from further analysis (n = 31), resulting in a patient pool of n = 454. MRI datasets analyzed included MRI of the abdomen and pelvis (n = 309, 68%), MRI of the small intestine/ MRI Sellink (n = 125, 27.5%), hips (n = 17, 3.7%), and rectum, prostate, and kidneys (n = 1 each, 0.2%). Patient characteristics including clinical data are summarized in Table 2.
Fat metaplasia across age groups
Fat metaplasia was very common and was observed in 50.6% of patients < 45 years and 94.4% of patients ≥ 75 years. Table 3 shows detailed distribution of patterns of fat metaplasia across all age groups, for male and female patients. Focal (score of 1) and patchy (score of 2) deposition patterns were the predominant findings in patients ≤ 45 years, while more confluent (score of 4) and extensive (score of 5) patterns increased in older age groups. Not only the prevalence but also the extent of fat metaplasia increased with age. The mean (± SD) sum scores of fat metaplasia increased from 0.89 (± 2.08) in patients ≤ 24 years to 11.56 (± 5.29) in patients ≥ 75 years. The correlation between age and extent of fat metaplasia was moderate, with a Pearson r of 0.550 (p < 0.001). The Jonckheere-Terpstra test showed that fat metaplasia was not distributed equally across age groups, independent of sex (p < 0.001), thereby confirming the age-dependent increase seen in Table 3.
Structural lesions
Structural lesions (i.e., sclerosis, erosions, and osteophytes) were observed at markedly lower frequencies than fat metaplasia. No case of ankylosis was observed in our study population. Table 4 presents the prevalence of structural lesions (excluding fat metaplasia) across age groups. In the age groups < 45 years, 10%, 0.6%, and 20% of patients had sclerosis, erosions, and osteophytes, respectively. Overall, osteophytes were significantly less prevalent in the female patient population (24.9% vs 48.5%, p < 0.001). Sex-specific prevalence for sclerosis (females: 16.3%, males: 11.2%; p = 0.133) or erosions (females: 4.1%, males: 1.3%; p = 0.081) may indicate a weak predilection for female patients, although neither trend was statistically significant.
Radiotherapy
Overall, 48 patients had undergone radiotherapy. Mean (± SD) sum scores for fat metaplasia were 10.30 (± 5.60) and 6.12 (± 5.52) for patients with a history of radiotherapy versus those without; the difference was highly significant (p < 0.001). However, Kendall tau c for the association of radiotherapy and fat metaplasia was very low at 0.157 (p < 0.001). Patients with a history of radiotherapy had a significantly higher mean age (62.33 vs 51.72 yrs, p < 0.001) than those without.
Immunosupression and hematological disease
Immunosuppressive agents were part of the medication of 222 patients of our study population. Mean (± SD) fat metaplasia sum scores for patients with and without immunosuppression did not differ significantly at 6.63 (± 5.58) and 6.50 (± 5.77), respectively. Immunosuppression and fat metaplasia were not associated significantly (Kendall tau c: 0.02, p = 0.703). Patients with immunosuppression were on average 51.95 years old, while patients without were on average 53.70 years; the difference was not statistically significant. Because only 2 patients had a hematological disease in our study population, its effect on fat metaplasia was not investigated further.
Osteoporosis
Patients diagnosed with osteoporosis (n = 31) had a significantly lower mean (± SD) sum score of fat metaplasia with 6.34 (± 5.59) compared to 11.29 (± 5.41) in patients without osteoporosis. The degree of association between osteoporosis and fat metaplasia was extremely low at a Kendall tau c of 0.09 (p < 0.001). Patients with osteoporosis were on average 52.28 years old, while patients without were on average 64.43 years; the difference was statistically significant (p < 0.001).
Suspected IBD
The study population included patients who underwent MRI for the detection of IBD (e.g., MRI Sellink and MRI of the small intestine). In this subset (n = 125), the frequency of sclerosis (14% in both Sellink group and all other patients) and erosions (4% in Sellink group vs 2% in all other patients) did not differ from all other patients. Fat metaplasia was less prevalent in the Sellink group (61% vs 75%, p = 0.005) and also less extensive, as expressed by mean sum scores of 4.69 versus 7.28 (p < 0.001).
Interrater reliability
ICC were computed to test for interrater reliability. ICC were 0.964 (95% CI 0.952–0.972) for fat metaplasia, 0.812 (95% CI 0.722–0.872) for joint space alterations, 0.826 (95% CI 0.744–0.882) for sclerosis, and 0.838 (95% CI 0.762–0.891) for osteophytes. All calculated coefficients were statistically significant (p < 0.001). Overall, ICC averaged at 0.860, indicating good interrater reliability22.
DISCUSSION
The aim of our analysis was to define the occurrence of changes typically associated with axSpA such as sclerosis, erosions, and fat metaplasia in periarticular bone marrow in the SIJ of a population without known axSpA. The results of our study show that periarticular fat metaplasia at the SIJ is a common finding and can be detected in up to 59.4% of patients ≤ 45 years without rheumatological disease. Additionally, our data demonstrate a significant age-dependent, sex-independent increase in the extent of these lesions. On the other hand, erosions are nearly absent in the age groups ≤ 45 years and are also an infrequent finding in age groups > 45 years, indicating that erosions are indeed rather specific for axSpA3,23,24.
Our observations underline the importance of precisely defining fat metaplasia as a structural lesion in axSpA-associated sacroiliitis. Fatty lesions, or fat metaplasia, have been described as part of the spectrum of axSpA since the 1990s11,25,26,27,28. Changes in the fat content of periarticular bone marrow are also used to evaluate the response to treatment5,29. Some data exist about the prevalence of structural lesions in healthy volunteers or patients with nonspecific back pain16,17,18,19; however, these control groups were not analyzed for fat metaplasia pattern or age distribution. Interestingly, analysis of patterns of fat metaplasia suggests an age-dependent transition from patchy lesions to more confluent ones. Further studies on healthy individuals may deepen our insights into the pathohistological mechanisms underlying this observation in the future.
Erosions are the hallmark of all forms of arthritis, and erosions are usually interpreted to suggest definite sacroiliitis in a clinical context. In our analysis, we concentrated on definite rather than probable erosions (e.g., slight joint contour irregularities). In the population investigated here, definite erosions were detected at a rather low frequency of 0.6% in the age groups < 45 years. The frequency of erosions did not dramatically increase with age and remained at a low 3% for the whole study population.
Sclerosis and osteophytes occurred in 10.0% and 20.0%, respectively, in patients < 45 years of age. However, prevalence increased with age and eventually reached 18.5% and 57.4%, respectively, in the age group ≥ 75 years. These frequencies are slightly lower than those reported by Eno, et al, who found degenerative changes in 65.1% of SIJ CT of asymptomatic patients30, which is best explained by the superior capacity of CT to detect osseous changes13. Additionally, the MRI protocols used in our study patients were not primarily intended for SIJ imaging; therefore, the slice thickness was 4 or 5 mm, and we analyzed axial images rather than the recommended oblique coronal planes2. As a result, more subtle changes may have gone undetected. This holds true especially for erosions, which are challenging to detect even in dedicated SIJ sequences.
Because we did not investigate a healthy population, possible clinical confounders in terms of fat metaplasia were taken into account in our analysis. It is well-established that radiation depletes hematopoietic red marrow, resulting in a higher fat content of irradiated areas9. In our analysis, patients with a history of radiotherapy had a significantly larger extent of fat metaplasia. We therefore conclude that because of inclusion of patients in post-irradiation status, our data may slightly overestimate the prevalence of fat metaplasia. Almost half of our patient population was taking immunosuppressive therapy. However, we found no significant association between immunosuppressive therapy and fat metaplasia identified by MRI. Because detailed data on amount and duration of treatment were not available in this retrospective setting, we cannot draw any conclusions regarding direct influences. Our findings regarding fat metaplasia in patients with osteoporosis appear unexpected: not only was fat metaplasia significantly less extensive in them, but the mean age of patients with osteoporosis was also significantly lower than that of patients without. A possible explanation is underreporting of osteoporosis in our electronic patient records, a known phenomenon in epidemiological studies31. In the general German population, the estimated prevalence of osteoporosis in individuals > 65 years of age is 12.1%32, while it was 8.5% in the respective part of our study population.
Another important confounder in our study is the substantial proportion of patients with proven or suspected IBD: > 25% of examinations were dedicated IBD examinations. The links between IBD and sacroiliitis have long been established33, and asymptomatic radiographic sacroiliitis in patients with IBD patients has a reported prevalence of 4–18%34,35. In our study population, however, these patients did not have more erosions or sclerosis, nor did they have significantly fewer osteophytes and less extensive fat metaplasia than the study population as a whole. We therefore assume that the inclusion of these patients did not lead to an overestimation of axSpA-associated changes.
MRI datasets were not specifically acquired to image SIJ and consequently, our scoring system was designed to evaluate the entire bones and not only the periarticular regions of the ilium and sacrum. However, to strongly attribute fat metaplasia to axSpA, a close proximity to the joint contour was mandatory3. Yet the scores of 1 (focal) and 2 (patchy) as defined in our scoring system are defined by the pattern within the bone, and a close relation to the cortical bone was not required. This limitation needs to be taken into account. Further, methodological limitations include the retrospective nature of our study design with some inherent selection bias. Also, further clinical confounders such as impaired mobility, multiparity, increased axial load, and altered spinal mechanics after spinal surgery were not investigated. As the presence of rheumatological disease could only be extracted from patient records, individuals with undiagnosed subclinical forms of the disease may have inadvertently been included. Future research should establish the prevalence of lesions in a healthy population, preferably excluding all clinical confounders by using a prospective study design.
Our study shows a very high prevalence of periarticular fat metaplasia adjacent to the SIJ in asymptomatic patients; this prevalence increases with age, while erosions are uncommon. Further research should be done to better define fat metaplasia in the context of axSpA, to avoid misinterpretation.
ONLINE SUPPLEMENT
Supplementary material accompanies the online version of this article.
Acknowledgment
We thank Bettina Herwig for language editing.
- Accepted for publication December 14, 2017.